Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mornex

Showing results (351-360 of 374) with videos related to

Pageof 38
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2009
[French radiotherapy database: results of a survey of French radiation oncology centers in 2007]B Chauvet, M Bolla, A Alies-Patin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2011
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]M Barhoumi, F Mornex, F Bonnetain, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2012
[Role of French teams in the development of clinical and translational research in radiation oncology]D Azria, J-M Ardiet, B Chauvet, et al.
Revue Des Maladies Respiratoires|March 16, 2005
[Biomarkers as prognostic factors in pulmonary arterial hypertension. Rationale and study design]J L Cracowski, A Yaici, O Sitbon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 23, 2012
[Dosimetric and clinical benefits of respiratory-gated radiotherapy for lung and breast cancers: results of the STIC 2003]P Giraud, J Djadi-Prat, E Morvan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1G Robinet, P Thomas, J L Breton, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 22, 2003
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]F Mornex, L Thomas, P Mohr, et al.
Melanoma Research|February 6, 2003
A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanomaF Mornex, L Thomas, P Mohr, et al.
Pulmonology|June 1, 2023
PI*ZQ0<sub>Attikon</sub> genotype discovery in severe alpha-1 antitrypsin deficiencyS A Papiris, M Veith, A Lazaratou, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2022
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancerJ Trédaniel, F Barlési, C Le Péchoux, et al.
Pageof 38

Showing results (351-360 of 374) with videos related to

Sort By:
Pageof 38
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2009
[French radiotherapy database: results of a survey of French radiation oncology centers in 2007]B Chauvet, M Bolla, A Alies-Patin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2011
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]M Barhoumi, F Mornex, F Bonnetain, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2012
[Role of French teams in the development of clinical and translational research in radiation oncology]D Azria, J-M Ardiet, B Chauvet, et al.
Revue Des Maladies Respiratoires|March 16, 2005
[Biomarkers as prognostic factors in pulmonary arterial hypertension. Rationale and study design]J L Cracowski, A Yaici, O Sitbon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 23, 2012
[Dosimetric and clinical benefits of respiratory-gated radiotherapy for lung and breast cancers: results of the STIC 2003]P Giraud, J Djadi-Prat, E Morvan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1G Robinet, P Thomas, J L Breton, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 22, 2003
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]F Mornex, L Thomas, P Mohr, et al.
Melanoma Research|February 6, 2003
A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanomaF Mornex, L Thomas, P Mohr, et al.
Pulmonology|June 1, 2023
PI*ZQ0<sub>Attikon</sub> genotype discovery in severe alpha-1 antitrypsin deficiencyS A Papiris, M Veith, A Lazaratou, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 9, 2022
Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancerJ Trédaniel, F Barlési, C Le Péchoux, et al.
Pageof 38